Dosing Regimen For A Selective Sip1 Receptor Agonist

Patent No. EP2278960 (titled "Dosing Regimen For A Selective Sip1 Receptor Agonist") was filed by Actelion Pharmaceuticals on Mar 12, 2009. The application was issued on Nov 13, 2019.

Patent Family

Statuses, jurisdictions and citation links are shared on request.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
HOLLATZ	Aug 29, 2017	TER MEER UND PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Oct 17, 2019
Decision to maintain the European patent in amended form
Oct 11, 2019
Termination of the opposition proceedings with maintenance of patent
Oct 2, 2019
(Electronic) Receipt
Oct 2, 2019
Filing of the translation of the amended claims
Oct 2, 2019
French translation of claims
Oct 2, 2019
German translation of the claims
Oct 2, 2019
Letter accompanying subsequently filed items
Jul 19, 2019
Communication of bibliographic data
Jul 19, 2019
Communication with request to file translations
Jul 9, 2019
Maintenance of the patent with the documents specified in the final decision
Apr 15, 2019
Advice of delivery
Mar 12, 2019
Advice of delivery
Mar 7, 2019
Acknowledgement of a document
Mar 7, 2019
Decision of the Opposition Division and instruction
Mar 7, 2019
Druckexemplar in opposition procedure
Mar 7, 2019
Grounds for the decision (Annex) - opposition
Mar 7, 2019
Interlocutory decision in opposition proceedings
Mar 7, 2019
Internal form - Opposition/addressees
Mar 7, 2019
Means of redress
Feb 1, 2019
Notification concerning the date of oral proceedings
Jan 30, 2019
(Electronic) Receipt
Jan 30, 2019
Claims
Jan 30, 2019
Description
Jan 30, 2019
Letter accompanying subsequently filed items
Jan 30, 2019
Written submission in preparation to/during oral proceedings
Jan 25, 2019
Annex to the communication
Jan 25, 2019
Brief communication - Opposition proceedings
Dec 4, 2018
(Electronic) Receipt
Dec 4, 2018
Amended claims with annotations
Dec 4, 2018
Amended claims with annotations
Dec 4, 2018
Amended claims with annotations
Dec 4, 2018
Amended claims with annotations
Dec 4, 2018
Claims
Dec 4, 2018
Claims
Dec 4, 2018
Claims
Dec 4, 2018
Claims
Dec 4, 2018
Letter accompanying subsequently filed items
Dec 4, 2018
Written submission in preparation to/during oral proceedings
Nov 15, 2018
Notification concerning the date of oral proceedings
Oct 2, 2018
Brief communication - Opposition proceedings
Oct 2, 2018
Brief communication - Opposition proceedings
Sep 24, 2018
(Electronic) Receipt
Sep 24, 2018
Letter accompanying subsequently filed items
Sep 24, 2018
Withdrawal of an opposition
Aug 14, 2018
Advice of delivery
Aug 14, 2018
Advice of delivery
Jul 19, 2018
Advice of delivery
Jul 17, 2018
Advice of delivery
Jul 10, 2018
Acknowledgement of a document
Jul 10, 2018
Acknowledgement of a document
Jul 10, 2018
Annex to the communication - opposition
Jul 10, 2018
Information concerning oral proceedings
Jul 10, 2018
Preparation for oral proceedings
Jul 10, 2018
Summons to attend oral proceedings
Jul 10, 2018
Summons to attend oral proceedings
Feb 26, 2018
Communication concerning the filing of a power of attorney
Feb 26, 2018
Communication of amended entries concerning the representative
Feb 22, 2018
Brief communication - Opposition proceedings
Feb 19, 2018
Authorisation
Feb 19, 2018
Claims
Feb 19, 2018
Reply of the patent proprietor to the notice(s) of opposition
Feb 16, 2018
Authorisation
Feb 16, 2018
Claims
Feb 16, 2018
Reply of the patent proprietor to the notice(s) of opposition
Oct 9, 2017
Communication of a notice of opposition and request to file observations
Oct 9, 2017
Notice of further oppositions to opponent(s)
Sep 11, 2017
Communication of a notice of opposition - first information to patent proprietor
Aug 29, 2017
(Electronic) Receipt
Aug 29, 2017
Non-patent literature cited during the opposition procedure
Aug 29, 2017
Non-patent literature cited during the opposition procedure
Aug 29, 2017
Non-patent literature cited during the opposition procedure
Aug 29, 2017
Non-patent literature cited during the opposition procedure
Aug 29, 2017
Notice of opposition
Aug 29, 2017
Notice of opposition
Aug 29, 2017
Patent document cited during the opposition procedure
Nov 30, 2016
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Nov 4, 2016
Decision to grant a European patent
Oct 18, 2016
(Electronic) Receipt
Oct 18, 2016
Filing of the translations of the claims
Oct 18, 2016
French translation of claims
Oct 18, 2016
German translation of the claims
Oct 18, 2016
Letter accompanying subsequently filed items
Sep 9, 2016
Bibliographic data of the European patent application
Sep 9, 2016
Communication about intention to grant a European patent
Sep 9, 2016
Intention to grant (signatures)
Sep 9, 2016
Text intended for grant (clean copy)
Sep 9, 2016
Text intended for grant (version for approval)
Aug 26, 2016
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Aug 10, 2016
(Electronic) Receipt
Aug 10, 2016
Letter accompanying subsequently filed items
Aug 10, 2016
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
May 6, 2016
Bibliographic data of the European patent application
May 6, 2016
Communication about intention to grant a European patent
May 6, 2016
Intention to grant (signatures)
May 6, 2016
Text intended for grant (clean copy)
May 6, 2016
Text intended for grant (version for approval)
Apr 14, 2016
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Mar 23, 2016
(Electronic) Receipt
Mar 23, 2016
Amended claims with annotations
Mar 23, 2016
Amended description with annotations
Mar 23, 2016
Claims
Mar 23, 2016
Description
Mar 23, 2016
Letter accompanying subsequently filed items
Mar 23, 2016
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Jan 28, 2016
Bibliographic data of the European patent application
Jan 28, 2016
Communication about intention to grant a European patent
Jan 28, 2016
Intention to grant (signatures)
Jan 28, 2016
Text intended for grant (clean copy)
Jan 28, 2016
Text intended for grant (version for approval)
Oct 30, 2014
(Electronic) Receipt
Oct 30, 2014
Amended claims with annotations
Oct 30, 2014
Amended description with annotations
Oct 30, 2014
Claims
Oct 30, 2014
Description
Oct 30, 2014
Letter accompanying subsequently filed items
Oct 30, 2014
Reply to communication from the Examining Division
Sep 1, 2014
Grant of extension of time limit (examination procedure)
Aug 26, 2014
(Electronic) Receipt
Aug 26, 2014
Letter accompanying subsequently filed items
Aug 26, 2014
Request for extension of time limit to communication from the Examining Division
May 2, 2014
Annex to the communication
May 2, 2014
Communication from the Examining Division
Jun 12, 2013
(Electronic) Receipt
Jun 12, 2013
Amended claims with annotations
Jun 12, 2013
Claims
Jun 12, 2013
Letter accompanying subsequently filed items
Jun 12, 2013
Reply to communication from the Examining Division
Apr 22, 2013
Grant of extension of time limit (examination procedure)
Apr 17, 2013
(Electronic) Receipt
Apr 17, 2013
Letter accompanying subsequently filed items
Apr 17, 2013
Request for extension of time limit to communication from the Examining Division
Jan 4, 2013
Annex to the communication
Jan 4, 2013
Communication from the Examining Division
Sep 5, 2012
Decision to allow further processing
Jan 26, 2012
Amended claims with annotations
Jan 26, 2012
Claims
Jan 26, 2012
Reply to communication from the Examining Division
Jan 24, 2012
Amended claims with annotations
Jan 24, 2012
Claims
Jan 24, 2012
Reply to communication from the Examining Division
Nov 28, 2011
Application deemed to be withdrawn (no reply to communication from the Examining Division)
Aug 2, 2011
Grant of extension of time limit (examination procedure)
Jul 29, 2011
Request for extension of time limit to communication from the Examining Division
Jul 27, 2011
Request for extension of time limit to communication from the Examining Division
Apr 8, 2011
Annex to the communication
Apr 8, 2011
Communication from the Examining Division
Jan 5, 2011
Notification on forthcoming publication of bibliographic data
Nov 16, 2010
Amendments received before examination
Nov 15, 2010
Amended claims filed after receipt of (European) search report
Nov 15, 2010
Amended claims with annotations
Nov 15, 2010
Amendments received before examination
Oct 28, 2010
Communication concerning correction of deficiences in Written Opinion/amendment of application/payment of claims fee
Oct 5, 2010
Copy of the international preliminary report on patentability
Aug 4, 2010
Request for entry into the European phase
Jul 28, 2010
Information on entry into European phase
Oct 15, 2009
Priority document (electronically transmitted)
Sep 24, 2009
Copy of the international search report
Sep 24, 2009
Published international application - A1
Jul 16, 2009
Written opinion of the ISA, boxes No. I to VIII
Jul 16, 2009
Written opinion of the ISA, cover sheet
Jul 16, 2009
Written opinion of the ISA, supplemental box
Apr 1, 2009
Abstract
Apr 1, 2009
Claims
Apr 1, 2009
Description

EP2278960

ACTELION PHARMACEUTICALS

Application Number: EP09721703A
Filing Date: Mar 12, 2009
Status: Patent Maintained As Amended; Oct 11, 2019
Publication Date: Nov 13, 2019
External Links: Slate, Register , Google Patents

IP Verse

Dosing Regimen For A Selective Sip1 Receptor Agonist

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2278960